⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Shanghai Moyom Biotechnology Co., Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Shanghai Moyom Biotechnology Co., Ltd.
↗Shanghai, China
Shanghai Moyom Biotechnology (often referred to as MyBioTec) is a Chinese high-tech enterprise focused on the research, development, production, and sale of nanomedical biomaterials and absorbable Class III medical implants. The company is primarily known for its medical aesthetics brand, Aphranel, which utilizes proprietary calcium microsphere and hydrogel technologies for anti-aging and regenerative applications.
The company positions itself as a practitioner of 'medical aesthetics returning to the essence of medicine,' emphasizing rigorous clinical testing and innovative material science. Its product portfolio includes injectable biostimulators and anti-aging solutions, supported by patents in porous micro-nano microsphere technology and hydrogel sustained-release systems.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Medical Aesthetics / Regenerative Medicine
SIZE & FINANCIALS
Employees:1-50
Founded:2018
Ownership:private
Status:operating
FUNDING
Stage:Series B+
Investors:Shanghai Science and Technology Investment Corporation (Shanghai State-owned Assets Supervision and Administration Commission), Hengxu Capital (SAIC Motor), BoYuan Capital, Jinding Capital, Huagai Capital, BlueRun Ventures
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Aphranel series)
Modalities:Biomaterials, Injectables
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Chinese Academy of Sciences (Innovation Consortium)
COMPETITION
Position:Emerging
LINKS
Website:mybiotec.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Shanghai Moyom Biotechnology Co., Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.